Prices delayed by at least 15 minutes | Print
First Trust Global Funds Public Limited Company FIRSTTRUSTNYSEARCABIOTECHUCITS
Open
1491.4p
Previous close
1487.4p
Trade high
1497.495p
Year low
1,313.70p
Year high
1,560.00p
Replication method
Physical Full
Volume
2,822
Type
ETF
UCITS
Yes
Dividend yield
-
Ongoing charge
0.6
ISIN
IE00BL0L0H60
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Before investing please read:
Share price
Asset allocation
Top 10 holdings
Holdings 28/03/2024 | % of assets |
---|---|
Natera Inc | 4.96 |
Bruker Corp | 4.35 |
Halozyme Therapeutics Inc | 3.90 |
Mettler-Toledo International Inc | 3.71 |
Waters Corp | 3.69 |
Corcept Therapeutics Inc | 3.58 |
PTC Therapeutics Inc | 3.51 |
Repligen Corp | 3.50 |
argenx SE ADR | 3.47 |
United Therapeutics Corp | 3.46 |
Investment objective
The Fund seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the NYSE Arca Biotechnology Index℠ (the “Index”).
Asset class
ETFMorningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.